NOV 08, 2018 03:54 PM PST

What Cannabis Can Do

Diabetes, often referred to by doctors as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body's cells do not respond properly to insulin, or both. In 2013 it was estimated that more than 382 million people in the world had some form of diabetes.
Israeli researchers are working on ways to use cannabis receptors to provide diabetes medication.
Israeli scientists are testing a cannabis-based therapy for diabetes. Researchers at the Hebrew University of Jerusalem have tracked down a specific chemical compound in the cannabis plant, a cannabinoid called "cannabidiol" that researchers say can be used to treat diabetes. The best source for cannabidiol, or CBD, is hemp.

Dr. Raphael Mechoulam, the researcher known for discovering CBD, has collaborated with researcher Dr. Ruth Gallily, also from Hebrew University. Dr. Mechoulam discovered receptors for cannabinoids in the brain and in other body tissues, opening up an entirely new area of research into how coucannabinoids could be modified to fit different receptors to treat different illnesses.

Meanwhile, the discovery is already becoming a marketable commodity. An Israeli company called ISA Scientific signed a worldwide collaboration and licensing deal with Yissum, the technology-transfer company of Hebrew University; Hadasit, the technology-transfer company of Hadassah Medical Organization of Jerusalem; and KIR, the Kennedy Trust for Rheumatology Research in the UK.

The deal enables the creation and development of specific therapies using cannabidiol (CBD) by the inter-disciplinary research team headed by Mechoulam. KIR director/immunologist Sir Marc Feldman is also involved in the effort, as are Hadassah researchers and physicians Chaim Lotan, Lolan Weiss and Ronen Durst.

There are Phase I clinical trials on dosing and safety underway in Israel, according to ISA Scientific CEO Mark J. Rosenfeld. "Arrangements for Phase 2 trials on treating diabetes and chronic pain are in process," he said in a statement.

As Rosenfeld explained, the firm's Israeli research and development team had been working on the issue of an oral delivery system. Because very little CBD reaches the bloodstream when taken by mouth, it is necessary to create a more efficient system, he said. The problem was solved "with proprietary nanotechnology" currently being integrated into the firm's clinical trials.

According to Rosenfeld, CBD seems to have no major side effects. It does not affect activities such as work, school, sports or driving. In addition, the company said that it is working towards creating a way to "control diabetes into the medical market place."

"CBD may even help prevent diabetes," Rosenfeld said.

Sources: Holistic Primary Care, Mayo Clinic

About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
OCT 11, 2018
Cannabis Sciences
OCT 11, 2018
Vaping Cannabis
What is vaping? Briefly, it is the heating up of plant material to a certain temperature that, instead of combusting, it vaporizes into an aerosol form. Va...
OCT 11, 2018
Cannabis Sciences
OCT 11, 2018
How Marijuana Will Affect Your Workout
THC (Tetrahydrocannabinol) has been found to give exercise an extra boost as the body burns off fat. THC the main psychoactive ingredient in cann...
OCT 31, 2018
Cannabis Sciences
OCT 31, 2018
Pot Stocks: What Investors Should Know
It was only a matter of time. With the legalization of recreational marijuana in Canada and 9 states in the US plus Washington DC, the marijuana industry i...
DEC 09, 2018
Cannabis Sciences
DEC 09, 2018
Targeting CB1 Endocannabinoid Receptor: Specificity is the Key
The human endocannabinoid system (ECS) is one of the body's largest network of neurotransmitters, receptors, and neuromodulators. This system plays a r...
DEC 19, 2018
Cannabis Sciences
DEC 19, 2018
What is the Connection Between Rastafarianism and Marijuana?
Marijuana has received a lot of attention for its medicinal and recreational purposes. But we should be mindful of the...
JAN 03, 2019
Cannabis Sciences
JAN 03, 2019
The Endocannabinoid System and Why We Should Care
The nervous system, the cardiovascular system, the skeletal system, the endocrine system; these are all physiological systems that have probably made it in...
Loading Comments...